PRKN and viral infectious disease: Notably we show that under conditions of viral infection in both experimental and clinical cases the expression of Parkin is suppressed by the virus, thus relieving a braking system that will lead to accumulation of damaged mitochondria, high levels of mtROS and NLRP3 activation, and the triggering of NLRP3-driven antiviral inflammation.